Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | PHGDH | O43175 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MLYCD | O95822 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8946061 | 1.00 | LMNA (0.59) | LMNAL3MBTL1PKMROCK2KDM4E | |
| SCHEMBL9408595 | 0.89 | ROCK2 (0.59) | LMNAL3MBTL1PKMROCK2KDM4E | |
| SCHEMBL8905438 | 0.88 | ROCK2 (0.60) | LMNAL3MBTL1PKMROCK2KDM4E | |
| SCHEMBL11178753 | 0.84 | LMNA (0.52) | LMNAL3MBTL1PKMKDM4ENPC1 | |
| SCHEMBL11039869 | 0.83 | LMNA (0.42) | LMNAL3MBTL1PKMROCK2KDM4E | |
| SCHEMBL2433724 | 0.82 | ROCK2 (0.50) | LMNAL3MBTL1ROCK2NPC1RAB9A | |
| SCHEMBL5255044 | 0.81 | PKM (0.53) | LMNAL3MBTL1PKMKDM4ENPC1 | |
| SCHEMBL5814273 | 0.81 | ROCK2 (0.53) | LMNAL3MBTL1ROCK2KDM4ERAB9A | |
| SCHEMBL9018864 | 0.81 | PKM (0.53) | LMNAL3MBTL1PKMKDM4ENPC1 | |
| SCHEMBL11554950 | 0.81 | PKM (0.53) | LMNAL3MBTL1PKMKDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 702 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120041182-A | Particle size-controllable epoxy resin fracturing propping agent and preparation method thereof | 江苏扬农化工集团有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-119752183-A | Preparation method of epoxy resin fracturing propping agent with high heat resistance and low breakage rate | 江苏扬农化工集团有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119638954-A | Phenolic epoxy resin and preparation method and application thereof | 江苏扬农化工集团有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-107922583-B | One-component toughened epoxy adhesives with improved adhesion to oily surfaces and high resistance to washout | DDP特种电子材料美国有限责任公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118006081-A | Epoxy resin for carbon fiber prepreg toughened by core-shell particles and preparation method thereof | 安徽赢碳新材料科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117659615-A | Epoxy resin composition, preparation method, prepreg and composite material thereof | 航天材料及工艺研究所 | 2024-03-08 | — | — | CN | claimed |
| US-20230390237-A1 | IMMUNOMODULATING UREA AZALIDES | ZOETIS SERVICES LLC | 2023-12-07 | — | — | US | claimed |
| CN-115397898-B | Epoxy resin composition for fiber-reinforced composite material, prepreg, and fiber-reinforced composite material | 横滨橡胶株式会社 | 2023-11-14 | — | — | CN | claimed |
| US-20230295389-A1 | PREPREG, MOLDED ARTICLE AND EPOXY RESIN COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | claimed |
| EP-4245783-A1 | PREPREG, MOLDED ARTICLE AND EPOXY RESIN COMPOSITION | Mitsubishi Chemical Corporation (JP) | 2023-09-20 | — | — | EP | claimed |
| JP-2004527587-A | — | — | 2004-09-09 | — | — | JP | claimed |
| EP-1023413-B1 | FLEXIBLE EPOXY SOUND DAMPING COATINGS | DOW GLOBAL TECHNOLOGIES INC (US) | 2004-09-01 | — | — | EP | claimed |
| EP-1400342-A2 | Composite pressure container or tubular body and composite intermediate | Mitsubishi Rayon Co., Ltd. (JP) | 2004-03-24 | — | — | EP | claimed |
| US-20040052997-A1 | Composite pressure container or tubular body and composite intermediate | MITSUBISHI RAYON COMPANY, LTD. (JP) | 2004-03-18 | — | — | US | claimed |
| US-20030168251-A1 | Preparation of crosslinked particles from polymers having activatible crosslinking groups | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2003-09-11 | — | — | US | claimed |
| EP-1287069-A1 | SOUND DEADENING AND STRUCTURAL REINFORCEMENT COMPOSITIONS AND METHODS OF USING THE SAME | Sika Corporation (US) | 2003-03-05 | — | — | EP | claimed |
| WO-2001088033-A1 | SOUND DEADENING AND STRUCTURAL REINFORCEMENT COMPOSITIONS AND METHODS OF USING THE SAME | SIKA CORPORATION (US) | 2001-11-22 | — | — | WO | claimed |
| CN-1164174-A | Antidote composition and method of using the same | NITROKEMIA RT (HU) | 1997-11-05 | — | — | CN | claimed |
| WO-1996015667-A2 | ANTIDOTE COMPOSITION AND METHOD FOR USE OF THE COMPOSITION | Nitrokémia Rt. (HU) | 1996-05-30 | — | — | WO | claimed |
| US-4072712-A | FROM ISOCYANATES, CATALYSIS | BAYER AKTIENGESELLSCHAFT (DT) | 1978-02-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230390237-A1 | IMMUNOMODULATING UREA AZALIDES | ARG1, IL2, CD209 | LMNA 4881/4885L3MBTL1 1830/4885PKM 4593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.